Goldman Sachs’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-782,061
| Closed | -$18.6M | – | 5960 |
|
|
2023
Q3 | $18.6M | Buy |
782,061
+487,476
| +165% | +$9.17M | ﹤0.01% | 1870 |
|
|
2023
Q2 | $4.78M | Buy |
294,585
+101,427
| +53% | +$1.68M | ﹤0.01% | 3140 |
|
|
2023
Q1 | $3.36M | Sell |
193,158
-14,705
| -7% | -$264K | ﹤0.01% | 3418 |
|
|
2022
Q4 | $3.9M | Sell |
207,863
-17,207
| -8% | -$332K | ﹤0.01% | 3397 |
|
|
2022
Q3 | $3.98M | Buy |
225,070
+18,169
| +9% | +$315K | ﹤0.01% | 3338 |
|
|
2022
Q2 | $3.61M | Buy |
206,901
+57,646
| +39% | +$1.1M | ﹤0.01% | 3491 |
|
|
2022
Q1 | $3.12M | Sell |
149,255
-551,103
| -79% | -$10.6M | ﹤0.01% | 3819 |
|
|
2021
Q4 | $12.5M | Buy |
700,358
+226,961
| +48% | +$3.64M | ﹤0.01% | 2554 |
|
|
2021
Q3 | $6.67M | Buy |
473,397
+243,886
| +106% | +$3.79M | ﹤0.01% | 3104 |
|
|
2021
Q2 | $3.81M | Buy |
229,511
+118,956
| +108% | +$2.13M | ﹤0.01% | 3595 |
|
|
2021
Q1 | $2M | Sell |
110,555
-277,918
| -72% | -$5.48M | ﹤0.01% | 3983 |
|
|
2020
Q4 | $7.09M | Sell |
388,473
-257,509
| -40% | -$4.08M | ﹤0.01% | 2729 |
|
|
2020
Q3 | $8.23M | Buy |
645,982
+147,962
| +30% | +$1.89M | ﹤0.01% | 2490 |
|
|
2020
Q2 | $5.47M | Buy |
498,020
+97,749
| +24% | +$1.01M | ﹤0.01% | 2736 |
|
|
2020
Q1 | $4.18M | Buy |
400,271
+93,656
| +31% | +$1.21M | ﹤0.01% | 2785 |
|
|
2019
Q4 | $4.93M | Buy |
306,615
+39,172
| +15% | +$647K | ﹤0.01% | 2971 |
|
|
2019
Q3 | $4.19M | Buy |
267,443
+31,121
| +13% | +$518K | ﹤0.01% | 2992 |
|
|
2019
Q2 | $4.7M | Buy |
236,322
+20,677
| +10% | +$386K | ﹤0.01% | 2889 |
|
|
2019
Q1 | $3.63M | Buy |
215,645
+57,345
| +36% | +$994K | ﹤0.01% | 3218 |
|
|
2018
Q4 | $2.4M | Buy |
158,300
+16,389
| +12% | +$281K | ﹤0.01% | 3418 |
|
|
2018
Q3 | $2.85M | Buy |
141,911
+3,324
| +2% | +$70.5K | ﹤0.01% | 3352 |
|
|
2018
Q2 | $2.7M | Sell |
138,587
-81,076
| -37% | -$1.28M | ﹤0.01% | 3415 |
|
|
2018
Q1 | $3M | Sell |
219,663
-67,752
| -24% | -$893K | ﹤0.01% | 3287 |
|
|
2017
Q4 | $3.9M | Sell |
287,415
-109,757
| -28% | -$1.58M | ﹤0.01% | 3243 |
|
|
2017
Q3 | $6.25M | Buy |
397,172
+113,045
| +40% | +$1.82M | ﹤0.01% | 2949 |
|
|
2017
Q2 | $4.89M | Buy |
284,127
+9,380
| +3% | +$143K | ﹤0.01% | 3076 |
|
|
2017
Q1 | $4.19M | Buy |
274,747
+122,290
| +80% | +$1.8M | ﹤0.01% | 3089 |
|
|
2016
Q4 | $2M | Sell |
152,457
-35,080
| -19% | -$449K | ﹤0.01% | 3855 |
|
|
2016
Q3 | $2.12M | Buy |
187,537
+113,038
| +152% | +$1.36M | ﹤0.01% | 3781 |
|
|
2016
Q2 | $887K | Sell |
74,499
-28,065
| -27% | -$377K | ﹤0.01% | 4301 |
|
|
2016
Q1 | $1.56M | Sell |
102,564
-260,890
| -72% | -$3.96M | ﹤0.01% | 3703 |
|
|
2015
Q4 | $5.86M | Buy |
363,454
+56,072
| +18% | +$819K | ﹤0.01% | 2683 |
|
|
2015
Q3 | $3.84M | Buy |
307,382
+254,731
| +484% | +$3.5M | ﹤0.01% | 3126 |
|
|
2015
Q2 | $873K | Sell |
52,651
-356,087
| -87% | -$5.74M | ﹤0.01% | 4662 |
|
|
2015
Q1 | $6.53M | Sell |
408,738
-1,466,934
| -78% | -$24.3M | ﹤0.01% | 2655 |
|
|
2014
Q4 | $29.2M | Sell |
1,875,672
-206,875
| -10% | -$3.02M | 0.01% | 1541 |
|
|
2014
Q3 | $28.7M | Sell |
2,082,547
-51,929
| -2% | -$788K | 0.01% | 1518 |
|
|
2014
Q2 | $34.3M | Buy |
2,134,476
+393
| +0% | +$6.22K | 0.01% | 1382 |
|
|
2014
Q1 | $36M | Buy |
2,134,083
+1,841,465
| +629% | +$33.4M | 0.01% | 1290 |
|
|
2013
Q4 | $6.16M | Sell |
292,618
-7,395
| -2% | -$167K | ﹤0.01% | 2847 |
|
|
2013
Q3 | $6.52M | Buy |
300,013
+259,710
| +644% | +$5.54M | ﹤0.01% | 2669 |
|
|
2013
Q2 | $754K | Buy |
+40,303
| New | +$735K | ﹤0.01% | 4611 |
|
Other funds holding NXGN
Goldman Sachs's NXGN Position: Q4 2023 in Review
Goldman Sachs sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 782,061 shares — an estimated $18.6M sold.
Goldman Sachs first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $36M in Q1 2014. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Goldman Sachs reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Goldman Sachs sold 782,061 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $18.6M.
- Goldman Sachs first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Goldman Sachs's NextGen Healthcare, Inc. Common Stock position peaked at $36M in Q1 2014.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.